Does Novo Nordisk’s Recent Recovery Signal More Gains Ahead in 2025?
Thinking about what to do with Novo Nordisk’s stock right now? You are definitely not alone. Whether you already own
Read More
Medical
Serena Williams weight loss with GLP-1 and its body image message
Lizzo reacts to ‘South Park’ remark about her and Ozempic Lizzo’s “worst fear” has come to light after being made
Read More
Trainee doctor accused of secretly recording video of hundreds of female colleagues in hospital restrooms
Melbourne, Australia — A trainee surgeon was released from custody on bail Friday after he was accused of secretly video recording
Read More
J&J to Invest $2B in North Carolina Manufacturing Facility
Johnson & Johnson, which promised in March to invest $55 billion to support U.S. manufacturing, will increase its presence in
Read More
CT Attorney General Tong Petitions the FDA to Remove Burdensome Restrictions on Mifepristone
Attorney General William Tong, 16 other attorneys general, and the governor of Pennsylvania this week petitioned the U.S. Food and
Read More
Patient speaks out as former Cincinnati Children’s doctor faces child porn charges
A family is speaking out as a former Cincinnati Children’s doctor faces child pornography charges.It comes as another local family
Read More
Advanz Pharma & Alvotech Gain European Approval for Mynzepli
Alvotech, a global biotech company, and Advanz Pharma Holdco Limited (Advanz Pharma), a UK-headquartered global pharmaceutical company, announced that the
Read More
1 Reason to Buy NVO
There’s more to the company’s leading product than meets the eye. It’s one thing for a pharmaceutical company to have
Read More
Ticks are migrating, but scant surveillance may leave doctors in the dark when it comes to treating patients : Shots
Carroll College professor of biology Grant Hokit drags a white cloth through brush outside of Condon, Mont., looking for ticks.
Read More
Disruption to traditional distribution channels to hinder pharma companies from adopting Trump’s DTC model, says GlobalData
In a significant shift for the US pharmaceutical landscape, President Donald Trump has formally announced in May 2025, a push
Read More